Lv4
704 积分 2024-09-13 加入
PNPLA3 inhibition: Replacing one Evil with the Other?
15小时前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
15小时前
已完结
Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties
9天前
已完结
Old target, but new drug: 2nd generation cetp inhibitor, CKD-508
9天前
已完结
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
12天前
已完结
Global epidemiology of dyslipidaemias
16天前
已完结
Chemically engineered antibodies for autophagy-based receptor degradation
20天前
已完结
Transferrin Receptor Targeting Chimeras (TransTACs) for Membrane Protein Degradation
21天前
已关闭
Targeting IL‐23 with Small Molecule Inhibitors: A New Horizon In Psoriasis Therapy
29天前
已完结
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
皖公网安备34019202002308
